Business UpdateJun 30, 2026, 04:17 PM
Pelthos Therapeutics Added to Russell 3000E Growth, Microcap Indexes
AI Summary
Pelthos Therapeutics Inc. announced its inclusion in the Russell 3000E™ Growth Benchmark, Russell Microcap®, and Russell Microcap® Growth Benchmark Indexes, effective June 29, 2026. CEO Scott Plesha highlighted that this inclusion reflects the company's significant progress and is expected to enhance its visibility within the investment community. The company aims to broaden awareness of its long-term growth opportunities as it continues to build a leading commercial-stage biopharmaceutical company.
Key Highlights
- Pelthos Therapeutics was added to the Russell 3000E™ Growth Benchmark Index.
- The company was also included in the Russell Microcap® Index.
- Pelthos Therapeutics is now part of the Russell Microcap® Growth Benchmark Index.
- Inclusion became effective when the US market opened on June 29, 2026.
- CEO Scott Plesha stated inclusion will enhance visibility and broaden awareness.
- Approximately $12.2 trillion in assets are benchmarked against Russell US indexes.
Price Impact
More from PTHS